a study on siddha trail drug KUTTATHIRKU CHOORANAM (INT) & VEPPAMPATTAI THYLAM (EXT) & PRANAYAAMAM (THERAPY) in patients having psoriasis
- Conditions
- THEATHRU KUTTAM (PSORIASIS)
- Registration Number
- CTRI/2018/05/013644
- Lead Sponsor
- government siddha medical college
- Brief Summary
This is an open clinical study to evaluate the efficacy of KUTTATHIRKUCHOORANAM (INT) VEPPAMPATTAI THYLAM (EXT) .8oomg of KUTTATHIRKU CHOORANAM and sufficient quantity of VEPPAMPATTAI THYLAM will be given for 48 days. PRANAYAAMAM (THERAPY) is given for all the patients.sample size is 40.the trail drugs KUTTATHIRKU CHOORANAM (INT) VEPPAMPATTAI THYLAM (EXT) contains some herbs and metals having anti-oxidant,immune modulator properties which will be helpful to manage psoriasis
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 40
Patches with Scaling Auspitz Sign positive Koebner’s Phenomenon positive.
Psoriasis with secondary infection in the lesions Alcoholism & Narcotic addicts History of long term intake of Steroids Cardiac disease Renal failure Pregnancy women and Lactating women Peptic ulcer Psoriatic Orthopedica.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method outcome is mainly assessed by reduction in clinical symptoms like itching and scaling.PASI Score (Psoriasis area severity index) 12 Months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
arignar anna hospital of indian medicine
🇮🇳Chennai, TAMIL NADU, India
arignar anna hospital of indian medicine🇮🇳Chennai, TAMIL NADU, IndiaDr K ThirugnanamPrincipal investigator8122462463rk.thiru73@gmail.com